Corrigendum: Calpain activation contributes to hyperglycemia-induced apoptosis in cardiomyocytes (Cardiovascular Research (2009) 84 (100-110) DOI: 10.1093/cvr/cvp189);Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes

Cardiovascular Research

Volumn 84, Issue 1, 2009, Pages 100-110

  Li, Ying ^a   Li, Yanwen ^b   Feng, Qingping ^a   Arnold, Malcolm ^a   Peng, Tianqing ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Calpain; Cardiomyocyte; High glucose; Na+ K+ ATPase; NADPH oxidase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM CHANNEL L TYPE; CALPAIN 1; CALPAIN 2; CALPASTATIN; GLUCOSE; GLYCOPROTEIN GP 91; OUABAIN; POTASSIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RYANODINE RECEPTOR; SMALL INTERFERING RNA; SODIUM; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALPAIN; CASPASE 3; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART VENTRICLE WALL; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CALCIUM; CALCIUM CHANNELS; CALCIUM-BINDING PROTEINS; CALPAIN; CASPASE 3; ENZYME ACTIVATION; HYPERGLYCEMIA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NADPH OXIDASE; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 70449713477     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvz094     Document Type: Erratum

References (39)

1. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 2008;371: 1800-1809.
2. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75.
3. De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 2004;25:656-662.d
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
5. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone Tet al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;117: 1610-1619.
6. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A et al. Myo-cardial cell death in human diabetes. Circ Res 2000;87:1123-1132.
7. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X et al. Attenuation by metal-lothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 2006;48:1688-1697.
8. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001;50:2363-2375.
9. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T et al. Antioxidant treatment attenuates hyperglycemia-induced cardio-myocyte death in rats. J Mol Cell Cardiol 2004;37:959-968.
10. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002;51:1938-1948.
11. Adeghate E. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 2004;261:187-191.
12. Cai L, Kang YJ. Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 2003;3:219-228.
13. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003;83:731-801.
14. Kent MP, Spencer MJ, Koohmaraie M. Postmortem proteolysis is reduced in transgenic mice overexpressing calpastatin. J Anim Sci 2004;82: 794-801.
15. Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP et al. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 2008;102:720-728.
16. Galvez AS, Diwan A, Odley AM, Hahn HS, Osinska H, Melendez JG et al. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ Res 2007;100:1071-1078.
17. Perrin C, Ecarnot-Laubriet A, Vergely C, Rochette L. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery. Cell Mol Biol (Noisy-le-grand) 2003;49:OL497-OL505 (Online).
18. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/ reperfusion. J Biol Chem 2001;276:30724-30728.
19. Bajaj G, Sharma RK. TNF-alpha-mediated cardiomyocyte apoptosis involves caspase-12 and calpain. Biochem Biophys Res Commun 2006; 345:1558-1564.
20. Li Y, Arnold JM, Pampillo M, Babwah AV, Peng T. Taurine prevents cardio-myocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free Radic Biol Med 2009;46:51-61.
21. Peng T, Shen E, Fan J, Zhang Y, Arnold JM, Feng Q. Disruption of phospho-lipase Cgamma1 signalling attenuates cardiac tumor necrosis factor-alpha expression and improves myocardial function during endotoxemia. Cardiovasc Res 2008;78:90-97.
22. Peng T, Lu X, Feng Q. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation 2005;111:1637-1644.
23. Fraser SF, McKenna MJ. Measurement of Na+, K+-ATPase activity in human skeletal muscle. Anal Biochem 1998;258:63-67.
24. Feng Q, Song W, Lu X, Hamilton JA, Lei M, Peng T et al. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002;106:873-879.
25. Inserte J, Garcia-Dorado D, Hernando V, Barba I, Soler-Soler J. Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion. Cardiovasc Res 2006;70: 364-373.
26. Babu PV, Sabitha KE, Shyamaladevi CS. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+-ATPase and Na+/K+-ATPase activity in the heart of streptozotocin-diabetic rats. Chem Biol Interact 2006;162:157-164.
27. Ramirez-Ortega M, Zarco G, Maldonado V, Carrillo JF, Ramos P, Ceballos G et al. Is digitalis compound-induced cardiotoxicity, mediated through guinea-pig cardiomyocytes apoptosis? Eur J Pharmacol 2007;566:34-42.
28. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(2) and systolic blood pressure in mice. Circ Res 2001;89:408-414.
29. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006;71:310-321.
30. Zalewska T, Thompson VF, Goll DE. Effect of phosphatidylinositol and inside-out erythrocyte vesicles on autolysis of mu-and m-calpain from bovine skeletal muscle. Biochim Biophys Acta 2004;1693:125-133.
31. Kennett SB, Roberts JD, Olden K. Requirement of protein kinase C micro activation and calpain-mediated proteolysis for arachidonic acid-stimulated adhesion of MDA-MB-435 human mammary carcinoma cells to collagen type IV. J Biol Chem 2004;279:3300-3307.
32. Raynaud F, Jond-Necand C, Marcilhac A, Furst D, Benyamin Y. Calpain 1-gamma filamin interaction in muscle cells: a possible in situ regulation by PKC-alpha. Int J Biochem Cell Biol 2006;38:404-413.
33. Shiraha H, Glading A, Chou J, Jia Z, Wells A. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol 2002;22: 2716-2727.
34. Matsumura Y, Saeki E, Otsu K, Morita T, Takeda H, Kuzuya T et al. Intra-cellular calcium level required for calpain activation in a single myocar-dial cell. J Mol Cell Cardiol 2001;33:1133-1142.
35. SmogorzewskiM, GalfayanV,Massry SG. High glucose concentration causes a rise in [Ca2+]i of cardiac myocytes. Kidney Int 1998;53:1237-1243.
36. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006;98:596-605.
37. Stalker TJ, Skvarka CB, Scalia R. A novel role for calpains in the endo-thelial dysfunction of hyperglycemia. FASEB J 2003;17:1511-1513.
38. Tan Y, Wu C, De Veyra T, Greer PA. Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 2006;281:17689-17698.
39. Lim CC, Zuppinger C, Guo X, Kuster GM, Helmes M, Eppenberger HM et al. Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J Biol Chem 2004;279:8290-8299.